Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.
about
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladderOptimal management of high-risk T1G3 bladder cancer: a decision analysisUpdate on the management of non-muscle invasive bladder cancer.Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.NBI - plasma vaporization hybrid approach in bladder cancer endoscopic management.Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.Saudi Oncology Society clinical management guidelines for urinary bladder cancer.N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.Is intravesical Bacillus Calmette-Guérin therapy superior to chemotherapy for intermediate-risk non-muscle-invasive bladder cancer? An ongoing debate.A pure microcytic bladder carcinoma synchronous to prostatic adenocarcinoma.Best practice in the treatment of nonmuscle invasive bladder cancer.Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer.Treatment of muscle-invasive bladder cancer: progress and new challenges.Feasibility of photoacoustic evaluations on dual-thermal treatment of ex vivo bladder tumors.The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer.The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.CUA guidelines on the management of non-muscle invasive bladder cancer.Recent advances in the treatment of bladder cancer.Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen?Controversial issues and optimal management of stage T1G3 bladder cancer.The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopyNew therapeutic targets in the management of urothelial carcinoma of the bladderIs en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study.Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer.Contemporary management of low-risk bladder cancer.Restaging transurethral resection of bladder tumor for high-risk stage Ta and T1 bladder cancer.Recent advances in urinary bladder cancer detection.Current strategies in the treatment of non-muscle-invasive bladder cancer.Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer.Optimal treatment of non-muscle invasive urothelial carcinoma including perioperative management revisited.Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.Mechanisms of recurrence of Ta/T1 bladder cancer.Is 'second-look' (re-staging) transurethral resection of bladder tumours a new standard of care?Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of AlbertaBudget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer.
P2860
Q26744756-9038A81A-5CA2-49C0-ABB0-5C336546035BQ26747775-74173E85-1B82-4A5D-9DED-80030BDA2F60Q33300413-DE49160F-1A22-4EE3-91D2-93915D3794ABQ33613070-A814E7CD-239C-40A7-80DC-828AFF4AC860Q33869233-45826AD0-3C5F-4FDF-88F3-05A922ACDCB0Q34147692-FEC5801A-73AB-477A-B6D5-A4A15AC03563Q34341148-26204305-ACF8-447F-941D-CDBC2ACE3C34Q34437299-69609636-19D8-49E6-9CA8-DB44AF570D85Q34997367-45640840-7409-483A-AB07-30CD6EF57BF0Q35051469-4CC3B3B2-D8AD-492D-A785-58E519288BE5Q35089307-D1CCAB06-0CAC-4AE2-BEF2-4A2A7A043457Q35526843-841CC16D-85AF-4F0F-8F95-81BC5F8078DCQ35688392-B92CC278-AA43-4166-92CE-69A6416F580BQ35937807-A195683E-7100-43BE-A3F7-8425F9736A62Q35987756-8B9D3264-FC7F-406A-8EE2-8004AC79C9F1Q36005169-2CBC69D7-600D-4AEE-B506-AAAB660D9C9EQ36217138-DE41D6FF-14D1-42E5-96BD-19FD1DC3BA48Q36253601-EFFC3C8D-D7BA-45BD-B448-55E7F1FF204EQ36312232-EBC932CF-A679-4AEC-A7D3-9F59EC532ADAQ36326208-E33EDB11-1322-4394-BE65-3833274F308DQ36334892-EDBE50C2-886F-4D09-9BC9-19F61A3E7E6DQ36426230-3BC9218F-2482-45F4-871D-F985F375A39FQ36573859-CECE70A1-D4AE-4D06-BC81-48CF77B19D4DQ36786491-88AF740F-9B2E-4718-931B-03CC5FD0164EQ37305943-863BDEB3-35AD-44A1-9DD9-DCB72AB074E3Q37707753-AFBBD33B-532C-4A20-BA1A-476D8B5E5333Q37813081-21E0CD27-DA28-4EE5-962B-2F0083E971DBQ37828064-1979B8D9-89D3-4922-BB75-8F448BF644D6Q37988400-B99EE49A-A1B0-4B50-A50C-A81636FD5813Q38030593-D5272220-2F4B-46DC-85FC-A455B8F4D4A9Q38048823-410C56BD-3BAF-449E-AB80-195BD0B2A1F2Q38180489-C7D099A0-F55A-47FE-86AD-5C89763A6A15Q38252387-B7897B5A-E4C3-4F9D-9A63-89C0E1BDF056Q38253205-46E58A19-8E97-47F1-A90E-F02D14569005Q38589612-326449EB-4C53-44E8-AA6F-157C21876752Q38636903-168D4324-DE52-485B-9435-0A5A41012903Q38682443-D08A17DD-7E31-482E-9E7C-B83C86C43CF3Q40609183-D0A3A4BA-AEE0-45DE-BEF3-14F9DD4ACF2FQ41607804-2B3379E9-7B0C-463B-A666-0207355ECA87Q42357046-13B2F09C-1E6B-4DCB-A8E1-93545AA757E8
P2860
Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Effect of routine repeat trans ...... long-term observational study.
@en
Effect of routine repeat trans ...... long-term observational study.
@nl
type
label
Effect of routine repeat trans ...... long-term observational study.
@en
Effect of routine repeat trans ...... long-term observational study.
@nl
prefLabel
Effect of routine repeat trans ...... long-term observational study.
@en
Effect of routine repeat trans ...... long-term observational study.
@nl
P2093
P1476
Effect of routine repeat trans ...... long-term observational study.
@en
P2093
Christine Steinhoff
Philipp Spiegelhalder
Rolf Ackermann
Thomas Alexander Vogeli
Xenia Simon
P304
P356
10.1097/01.JU.0000070437.14275.E0
P407
P433
P577
2003-08-01T00:00:00Z